Page 17 - Read Online

Page 12 of 12 Schaafsma et al. J Cancer Metastasis Treat 2021;7:34 https://dx.doi.org/10.20517/2394-4722.2021.72

24. Varn FS, Andrews EH, Mullins DW, Cheng C. Integrative analysis of breast cancer reveals prognostic haematopoietic activity and
patient-specific immune response profiles. Nat Commun 2016;7:10248. DOI PubMed PMC
25. Varn FS, Wang Y, Mullins DW, Fiering S, Cheng C. Systematic pan-cancer analysis reveals immune cell interactions in the tumor
microenvironment. Cancer Res 2017;77:1271-82. DOI PubMed PMC
26. Cheng C, Yan X, Sun F, Li LM. Inferring activity changes of transcription factors by binding association with sorted expression
profiles. BMC Bioinformatics 2007;8:452. DOI PubMed PMC
27. Coughlin CM, Fleming MD, Carroll RG, et al. Immunosurveillance and survivin-specific T-cell immunity in children with high-risk
neuroblastoma. J Clin Oncol 2006;24:5725-34. DOI PubMed
28. Slyper M, Porter CBM, Ashenberg O, et al. A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nat
Med 2020;26:792-802. DOI PubMed PMC
29. Helmink BA, Reddy SM, Gao J, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature
2020;577:549-55. DOI PubMed
30. Petitprez F, de Reyniès A, Keung EZ, et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature
2020;577:556-60. DOI PubMed
31. Cabrita R, Lauss M, Sanna A, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature
2020;577:561-5. DOI PubMed
32. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet 2007;369:2106-20. DOI PubMed PMC
+
33. der Leun AM, Thommen DS, Schumacher TN. CD8 T cell states in human cancer: insights from single-cell analysis. Nat Rev Cancer
2020;20:218-32. DOI PubMed PMC
34. Charoentong P, Finotello F, Angelova M, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships
and predictors of response to checkpoint blockade. Cell Rep 2017;18:248-62. DOI PubMed
35. Asgharzadeh S, Salo JA, Ji L, et al. Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. J Clin
Oncol 2012;30:3525-32. DOI PubMed PMC
36. Rubtsov AV, Rubtsova K, Kappler JW, Jacobelli J, Friedman RS, Marrack P. CD11c-expressing B cells are located at the T Cell/B cell
border in spleen and are potent APCs. J Immunol 2015;195:71-9. DOI PubMed PMC
37. Shi JY, Gao Q, Wang ZC, et al. Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with
favorable prognosis in hepatocellular carcinoma. Clin Cancer Res 2013;19:5994-6005. DOI PubMed
38. Coronella JA, Spier C, Welch M, et al. Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal
carcinoma of the breast. J Immunol 2002;169:1829-36. DOI PubMed
39. Sharonov GV, Serebrovskaya EO, Yuzhakova DV, Britanova OV, Chudakov DM. B cells, plasma cells and antibody repertoires in the
tumour microenvironment. Nat Rev Immunol 2020;20:294-307. DOI PubMed
40. Cavalli E, Mazzon E, Mammana S, et al. Overexpression of macrophage migration inhibitory factor and its homologue D-dopachrome
tautomerase as negative prognostic factor in neuroblastoma. Brain Sci 2019;9:284. DOI PubMed PMC